Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2012
JTCB. 2012 Apr 1; 10 (1) : 001-007

Relation of High Sensitive C-reactive Protein (HSCRP) and Obesity

1 Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya, Ankara
2 Tepecik Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya, İzmir

Abstract

Objective: Obesity is the leading public health problem in this century. In this study we aimed to evaluate the hsCRP levels which are the indicators of inflammation in obese people (defined with BMI) and assess the relation between obesity and hsCRP.

Materials and Methods: Study included 31 male and 77 female, totally 108 healthy individuals. According to body mass index (BMI) they were divided into 3 groups; 25 were in normal, 49 were in over-weighted and 34 were in obese group. HsCRP levels were measured with chemiluminescent immunometric assay. All results were evaluated statistically.

Results: HsCRP level difference was not significant between the normal and over-weighted groups (p=0.569), but levels were differed between the normal and obese groups (p<0.001), and between the over-weighted and obese groups (p=0.002). Insülin (r=0.274, p=0.004), BMI (r=0.495, p<0.001) and HOMA-IR (r=0.299, p=0.002) showed a positive correlation with HsCRP in all group.

Conclusion: When hsCRP levels of non-obese, over-weighted, and obese groups were compared, a significant relation was found between the hsCRP and obesity and also that hsCRP level increases in accordance with weight increase were demonstrated.

Citation

Hancı, Tuba, Hakan Türkön, Ayfer Çolak Aydoğdu, Ömür Yıldız, İsmail Karademirci, and Işıl Çoker. 2012. “Relation of High Sensitive C-Reactive Protein (HSCRP) and Obesity”. Journal of Turkish Clinical Biochemistry 10 (1):001-007. https://turkclinbiochem.org/index.php/pub/article/view/162.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.